What are the side effects of Slynd (drospirenone) progestin‑only oral contraceptive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Slynd Side Effects

Slynd (drospirenone 4 mg progestin-only pill) has common side effects including irregular menstrual bleeding, acne, headache, breast tenderness, weight gain, menstrual cramps, nausea, and decreased libido, with serious but rare risks of hyperkalemia, venous thromboembolism, and depression. 1

Common Side Effects

The most frequently reported side effects of Slynd include 1:

  • Irregular menstrual bleeding (most common, occurring in approximately 90% of users, especially during first few months) 2
  • Acne 1
  • Headache 1
  • Breast pain and tenderness 1
  • Weight gain 1
  • Menstrual cramps 1
  • Nausea 1
  • Decreased sexual desire 1

Bleeding Pattern Changes

Unscheduled bleeding is the most prominent side effect, with 91.6% of Japanese women experiencing it across all cycles, though this typically improves over time. 2 In clinical trials, the proportion of participants with any bleeding decreased from 72.7% in Cycle 1 to 32.1% by Cycle 13, and unscheduled bleeding decreased from 49.1% to 22.8% over the same period. 3 Prolonged bleeding occurs in approximately 6.5% during early cycles, decreasing to 4.2% by later cycles. 3

Serious Side Effects Requiring Immediate Medical Attention

Hyperkalemia (High Potassium Levels)

Hyperkalemia is a serious risk due to drospirenone's anti-mineralocorticoid properties, particularly in women with renal impairment or those taking potassium-sparing medications. 1 Seek emergency care if you experience 1:

  • Weakness or numbness in arm or leg
  • Palpitations or irregular heartbeat
  • Nausea or vomiting
  • Severe chest pain
  • Shortness of breath

Important caveat: Slynd is contraindicated in women with renal impairment, adrenal insufficiency, or those taking medications that increase potassium levels. 1

Venous Thromboembolism (Blood Clots)

While progestin-only pills generally have lower VTE risk than combined oral contraceptives, blood clots remain a serious concern. 1 Seek immediate medical attention for 1:

  • Leg pain that won't go away
  • Sudden severe headache unlike usual headaches
  • Sudden severe shortness of breath
  • Sudden vision changes or blindness
  • Chest pain
  • Weakness or numbness in arm or leg
  • Trouble speaking

Critical distinction: Unlike drospirenone-containing combined oral contraceptives (which have VTE rates of approximately 9-10 per 10,000 person-years), clinical trials of Slynd reported no cases of deep vein thrombosis or pulmonary embolism. 4, 3 However, Slynd is contraindicated in women with history of blood clots. 1

Depression and Mental Health

Depression is a serious side effect, especially in women with prior history of depression. 1 Call your healthcare provider immediately if you have thoughts of harming yourself. 1

Other Serious Risks

  • Bone loss: Unknown if the decrease in sex hormones with Slynd results in decreased bone density 1
  • Cervical cancer: Possible increased risk, though may be related to other factors like HPV exposure 1
  • Liver problems: Including rare liver tumors; seek care immediately for yellowing of skin or eyes 1
  • Ectopic pregnancy: If pregnancy occurs while using Slynd, higher risk of tubal pregnancy; seek emergency care for severe abdominal pain 1
  • High blood sugar: Women with diabetes may need more frequent monitoring or medication adjustments 1

Contraindications and High-Risk Situations

Slynd is absolutely contraindicated in women with 1:

  • Renal impairment
  • Hepatic impairment
  • Adrenal insufficiency
  • History of blood clots (DVT, PE, stroke, or MI)
  • Current or history of breast cancer or hormone-sensitive cancers

Monitoring Recommendations

Your healthcare provider may check potassium levels before and during treatment with Slynd, particularly if you have risk factors for hyperkalemia. 1 However, multiple large retrospective studies found no increased risk of hyperkalemia with drospirenone-containing contraceptives compared to other formulations, even when combined with spironolactone. 5

Tolerability and Acceptability

Despite the high rate of irregular bleeding, over 82% of subjects rated Slynd acceptability as "excellent/good" in clinical trials. 3 The bleeding patterns, while different from combined oral contraceptives, are generally more predictable than traditional progestin-only pills. 6, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.